Benjamin Chu

Stonybrook Technology & Applied Research, Inc. provides research and development of biomedical products. It has created a biomedical membrane that can be used inside the body to prevent adhesions, to administer antibiotics, painkillers and genetic therapies and to assist in tissue engineering. The company was founded by Dufei Fang, Benjamin S. Hsiao and Benjamin Chu in 2002 and is headquartered in Stony Brook, NY.

Liquidity Nanotech Corp. develops water filtration technologies. It engages in the development of water purification products, based on breakthrough membrane technology. The company was founded by Victor W. Hwang, Benjamin Hsiao, Benjamin Chu, Mark G. Kachur and Dean D. Spatz in 2009 and is headquartered in Alameda, CA.

Stonybrook's patented technology is the result of years of research by Ben Chu, Distinguished Professor of Chemistry, and Ben Hsiao, Chairman of the Chemistry Department, both at Stony Brook University, New York. Stonybrook Purification was co-founded by Professors Chu and Hsiao, and the company is on course to revolutionize the industry. Stonybrook's game-changing technology dramatically lowers the cost of making clean water with a new type of membrane platform. This technology helps solve one of the major bottlenecks in water purification: the slow speed of filtration membranes. By improving production speed and quality while reducing cost, water purification systems based on Stonybrook membranes will fulfill an enormous worldwide need in both the public and private sectors. Stonybrook's filtration solutions are built on a game-changing membrane platform. Until now, filtration systems have been limited by membrane performance. High flux meant high fouling. Structural strength created greater resistance and lower performance. Its membrane technology breakthrough removes the trade-off between open pore structure and stability. A Stonybrook system provides a quantum leap in productivity at a lower cost. Now the world can afford clean water.